The Biggest winner of the day was Esperion Therapeutics(ESPR) with shares skyrocketed 74.14% to $41.22 per share on expected FDA approval of new drug application. Another biotech winner was Nektar Therapeutics (NKTR) with shares surged 42.65% to $22.11 per share on successful phase 3 clinical trials.

Yet another biotech winner today was CytomX Therapeutics (CTMX) as shares jumped 24.44% to $18.89 per share as the company received $200 million royalty payment from Bristol-Myers Squibb. Moving to the material sector shares of Dominion Diamond Corp (DDC) surged 22.98% to $12.2 per share as the company may be acquired by Billionaire businessman Dennis R. Washington